Stock exchanges & markets

Overview Watchlists

Roche says EU regulator panel backs Susvimo approval for wet AMD

24. Jul 2026

(AWP Alliance News) - Roche won a positive CHMP opinion backing EU approval of Susvimo for neovascular age-related macular degeneration. The therapy uses a refillable eye implant to continuously deliver ranibizumab, aiming to cut treatment to two refills a year versus regular injections.

A European Commission decision is expected soon.

https://www.globenewswire.com/NewsRoom/ReleaseNg/402448010

Disclaimer: This news brief was created using generative artificial intelligence. Roche Holding AG published the original content used to generate this news brief via GlobeNewswire on July 24, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now